APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Therapy Medicine

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gene Therapy Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025183 pages

Choose your research edition.

Industry ResearchGene Therapy Medicine Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Therapy Medicine Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Gene Therapy Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Therapy Medicine Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Therapy Medicine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Gene Therapy Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Gene Therapy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gene Therapy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gene Therapy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gene Therapy Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gene Therapy Medicine include Vical Inc., Spark Therapeutics, Sangamo, Dimension Therapeutics, Celladon, Bluebird Bio, Avalanche Bio and Advantagene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Gene Therapy Medicine market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gene Therapy Medicine and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gene Therapy Medicine revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gene Therapy Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.

Gene Therapy Medicine Segment by Company

Vical Inc.

Spark Therapeutics

Sangamo

Dimension Therapeutics

Celladon

Bluebird Bio

Avalanche Bio

Advantagene

Gene Therapy Medicine Segment by Type

Oral

Injection

Gene Therapy Medicine Segment by Application

Cancer

Infectious Disease

Monogenic

Cardiovascular Disease

Other

Gene Therapy Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Therapy Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Therapy Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Therapy Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gene Therapy Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Therapy Medicine industry.

Chapter 3: Detailed analysis of Gene Therapy Medicine companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapy Medicinerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gene Therapy Medicine Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Oral Table 3. Key Players of Injection Table 4. Global Gene Therapy Medicine Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Cancer Table 6. Key Players of Infectious Disease Table 7. Key Players of Monogenic Table 8. Key Players of Cardiovascular Disease Table 9. Key Players of Other Table 10. Global Gene Therapy Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global Gene Therapy Medicine Market Size by Region (2021-2026) & (US$ Million) Table 12. Global Gene Therapy Medicine Market Share by Region (2021-2026) Table 13. Global Gene Therapy Medicine Market Size by Region (2027-2032) & (US$ Million) Table 14. Global Gene Therapy Medicine Market Share by Region (2027-2032) Table 15. Gene Therapy Medicine Industry Trends Table 16. Gene Therapy Medicine Industry Drivers Table 17. Gene Therapy Medicine Industry Opportunities and Challenges Table 18. Gene Therapy Medicine Industry Restraints Table 19. Global Gene Therapy Medicine Revenue by Company (US$ Million) & (2021-2026) Table 20. Global Gene Therapy Medicine Revenue Market Share by Company (2021-2026) Table 21. Global Gene Therapy Medicine Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global Gene Therapy Medicine Key Company Head Office and Area Served Table 23. Global Gene Therapy Medicine Company, Product Type & Application Table 24. Global Gene Therapy Medicine Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global Gene Therapy Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global Gene Therapy Medicine Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Gene Therapy Medicine Market Size by Type (2021-2026) & (US$ Million) Table 29. Global Gene Therapy Medicine Market Size by Type (2027-2032) & (US$ Million) Table 30. Global Gene Therapy Medicine Revenue Market Share by Type (2021-2026) Table 31. Global Gene Therapy Medicine Revenue Market Share by Type (2027-2032) Table 32. Global Gene Therapy Medicine Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Gene Therapy Medicine Market Size by Application (2021-2026) & (US$ Million) Table 34. Global Gene Therapy Medicine Market Size by Application (2027-2032) & (US$ Million) Table 35. Global Gene Therapy Medicine Revenue Market Share by Application (2021-2026) Table 36. Global Gene Therapy Medicine Revenue Market Share by Application (2027-2032) Table 37. Vical Inc. Company Information Table 38. Vical Inc. Business Overview Table 39. Vical Inc. Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Vical Inc. Gene Therapy Medicine Product Portfolio Table 41. Vical Inc. Recent Development Table 42. Spark Therapeutics Company Information Table 43. Spark Therapeutics Business Overview Table 44. Spark Therapeutics Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Spark Therapeutics Gene Therapy Medicine Product Portfolio Table 46. Spark Therapeutics Recent Development Table 47. Sangamo Company Information Table 48. Sangamo Business Overview Table 49. Sangamo Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Sangamo Gene Therapy Medicine Product Portfolio Table 51. Sangamo Recent Development Table 52. Dimension Therapeutics Company Information Table 53. Dimension Therapeutics Business Overview Table 54. Dimension Therapeutics Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Dimension Therapeutics Gene Therapy Medicine Product Portfolio Table 56. Dimension Therapeutics Recent Development Table 57. Celladon Company Information Table 58. Celladon Business Overview Table 59. Celladon Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Celladon Gene Therapy Medicine Product Portfolio Table 61. Celladon Recent Development Table 62. Bluebird Bio Company Information Table 63. Bluebird Bio Business Overview Table 64. Bluebird Bio Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Bluebird Bio Gene Therapy Medicine Product Portfolio Table 66. Bluebird Bio Recent Development Table 67. Avalanche Bio Company Information Table 68. Avalanche Bio Business Overview Table 69. Avalanche Bio Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Avalanche Bio Gene Therapy Medicine Product Portfolio Table 71. Avalanche Bio Recent Development Table 72. Advantagene Company Information Table 73. Advantagene Business Overview Table 74. Advantagene Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Advantagene Gene Therapy Medicine Product Portfolio Table 76. Advantagene Recent Development Table 77. North America Gene Therapy Medicine Market Size by Type (2021-2026) & (US$ Million) Table 78. North America Gene Therapy Medicine Market Size by Type (2027-2032) & (US$ Million) Table 79. North America Gene Therapy Medicine Market Size by Application (2021-2026) & (US$ Million) Table 80. North America Gene Therapy Medicine Market Size by Application (2027-2032) & (US$ Million) Table 81. North America Gene Therapy Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 82. North America Gene Therapy Medicine Market Size by Country (2021-2026) Table 83. North America Gene Therapy Medicine Market Size by Country (2027-2032) Table 84. Europe Gene Therapy Medicine Market Size by Type (2021-2026) & (US$ Million) Table 85. Europe Gene Therapy Medicine Market Size by Type (2027-2032) & (US$ Million) Table 86. Europe Gene Therapy Medicine Market Size by Application (2021-2026) & (US$ Million) Table 87. Europe Gene Therapy Medicine Market Size by Application (2027-2032) & (US$ Million) Table 88. Europe Gene Therapy Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. Europe Gene Therapy Medicine Market Size by Country (2021-2026) Table 90. Europe Gene Therapy Medicine Market Size by Country (2027-2032) Table 91. China Gene Therapy Medicine Market Size by Type (2021-2026) & (US$ Million) Table 92. China Gene Therapy Medicine Market Size by Type (2027-2032) & (US$ Million) Table 93. China Gene Therapy Medicine Market Size by Application (2021-2026) & (US$ Million) Table 94. China Gene Therapy Medicine Market Size by Application (2027-2032) & (US$ Million) Table 95. Asia Gene Therapy Medicine Market Size by Type (2021-2026) & (US$ Million) Table 96. Asia Gene Therapy Medicine Market Size by Type (2027-2032) & (US$ Million) Table 97. Asia Gene Therapy Medicine Market Size by Application (2021-2026) & (US$ Million) Table 98. Asia Gene Therapy Medicine Market Size by Application (2027-2032) & (US$ Million) Table 99. Asia Gene Therapy Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Asia Gene Therapy Medicine Market Size by Country (2021-2026) Table 101. Asia Gene Therapy Medicine Market Size by Country (2027-2032) Table 102. South America, Middle East & Africa Gene Therapy Medicine Market Size by Type (2021-2026) & (US$ Million) Table 103. South America, Middle East & Africa Gene Therapy Medicine Market Size by Type (2027-2032) & (US$ Million) Table 104. South America, Middle East & Africa Gene Therapy Medicine Market Size by Application (2021-2026) & (US$ Million) Table 105. South America, Middle East & Africa Gene Therapy Medicine Market Size by Application (2027-2032) & (US$ Million) Table 106. South America, Middle East & Africa Gene Therapy Medicine Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. South America, Middle East & Africa Gene Therapy Medicine Market Size by Country (2021-2026) Table 108. South America, Middle East & Africa Gene Therapy Medicine Market Size by Country (2027-2032) Table 109. Research Programs/Design for This Report Table 110. Authors List of This Report Table 111. Secondary Sources Table 112. Primary Sources List of Figures Figure 1. Gene Therapy Medicine Product Image Figure 2. Global Gene Therapy Medicine Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Gene Therapy Medicine Market Share by Type: 2025 VS 2032 Figure 4. Oral Image Figure 5. Injection Image Figure 6. Global Gene Therapy Medicine Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Gene Therapy Medicine Market Share by Application: 2025 VS 2032 Figure 8. Cancer Image Figure 9. Infectious Disease Image Figure 10. Monogenic Image Figure 11. Cardiovascular Disease Image Figure 12. Other Image Figure 13. Global Gene Therapy Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 15. Global Gene Therapy Medicine Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Gene Therapy Medicine Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Gene Therapy Medicine Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Gene Therapy Medicine Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Gene Therapy Medicine Revenue Market Share by Type (2021-2032) Figure 22. Global Gene Therapy Medicine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Gene Therapy Medicine Revenue Market Share by Application (2021-2032) Figure 24. North America Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 25. North America Gene Therapy Medicine Market Share by Type (2021-2032) Figure 26. North America Gene Therapy Medicine Market Share by Application (2021-2032) Figure 27. North America Gene Therapy Medicine Market Share by Country (2021-2032) Figure 28. United States Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 29. Canada Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 31. Europe Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 32. Europe Gene Therapy Medicine Market Share by Type (2021-2032) Figure 33. Europe Gene Therapy Medicine Market Share by Application (2021-2032) Figure 34. Europe Gene Therapy Medicine Market Share by Country (2021-2032) Figure 35. Germany Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 36. France Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 38. Italy Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 39. Russia Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 41. China Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 42. China Gene Therapy Medicine Market Share by Type (2021-2032) Figure 43. China Gene Therapy Medicine Market Share by Application (2021-2032) Figure 44. Asia Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 45. Asia Gene Therapy Medicine Market Share by Type (2021-2032) Figure 46. Asia Gene Therapy Medicine Market Share by Application (2021-2032) Figure 47. Asia Gene Therapy Medicine Market Share by Country (2021-2032) Figure 48. Japan Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 52. India Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 53. Australia Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Gene Therapy Medicine Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Gene Therapy Medicine Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Gene Therapy Medicine Market Share by Country (2021-2032) Figure 58. Brazil Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 63. UAE Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 65. Chile Gene Therapy Medicine Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Cancer
  • Infectious Disease
  • Monogenic
  • Cardiovascular Disease
  • Other
Companies covered
  • Vical Inc.
  • Spark Therapeutics
  • Sangamo
  • Dimension Therapeutics
  • Celladon
  • Bluebird Bio
  • Avalanche Bio
  • Advantagene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Gene Therapy Medicine Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Injection
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Gene Therapy Medicine Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Cancer
  9. 1.3.3 Infectious Disease
  10. 1.3.4 Monogenic
  11. 1.3.5 Cardiovascular Disease
  12. 1.3.6 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Gene Therapy Medicine Growth Trends by Region
  15. 1.5.1 Global Gene Therapy Medicine Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Gene Therapy Medicine Market Size by Region (2021-2026)
  17. 1.5.3 Gene Therapy Medicine Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Gene Therapy Medicine Market Dynamics
  1. 2.1 Gene Therapy Medicine Industry Trends
  2. 2.2 Gene Therapy Medicine Industry Drivers
  3. 2.3 Gene Therapy Medicine Industry Opportunities and Challenges
  4. 2.4 Gene Therapy Medicine Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Gene Therapy Medicine Revenue by Company (2021-2026)
  2. 3.2 Global Gene Therapy Medicine Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Gene Therapy Medicine Key Company Head office and Area Served
  4. 3.4 Global Gene Therapy Medicine Company, Product Type & Application
  5. 3.5 Global Gene Therapy Medicine Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Gene Therapy Medicine Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Gene Therapy Medicine Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Gene Therapy Medicine Tier 1, Tier 2, and Tier 3
4 Gene Therapy Medicine Market by Type
  1. 4.1 Global Gene Therapy Medicine Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Gene Therapy Medicine Market Size by Type (2021-2032)
  3. 4.3 Global Gene Therapy Medicine Market Size Share by Type (2021-2032)
5 Gene Therapy Medicine Market by Application
  1. 5.1 Global Gene Therapy Medicine Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Gene Therapy Medicine Market Size by Application (2021-2032)
  3. 5.3 Global Gene Therapy Medicine Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Vical Inc.
  2. 6.1.1 Vical Inc. Company Information
  3. 6.1.2 Vical Inc. Business Overview
  4. 6.1.3 Vical Inc. Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Vical Inc. Gene Therapy Medicine Product Portfolio
  6. 6.1.5 Vical Inc. Recent Developments
  7. 6.2 Spark Therapeutics
  8. 6.2.1 Spark Therapeutics Company Information
  9. 6.2.2 Spark Therapeutics Business Overview
  10. 6.2.3 Spark Therapeutics Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Spark Therapeutics Gene Therapy Medicine Product Portfolio
  12. 6.2.5 Spark Therapeutics Recent Developments
  13. 6.3 Sangamo
  14. 6.3.1 Sangamo Company Information
  15. 6.3.2 Sangamo Business Overview
  16. 6.3.3 Sangamo Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Sangamo Gene Therapy Medicine Product Portfolio
  18. 6.3.5 Sangamo Recent Developments
  19. 6.4 Dimension Therapeutics
  20. 6.4.1 Dimension Therapeutics Company Information
  21. 6.4.2 Dimension Therapeutics Business Overview
  22. 6.4.3 Dimension Therapeutics Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Dimension Therapeutics Gene Therapy Medicine Product Portfolio
  24. 6.4.5 Dimension Therapeutics Recent Developments
  25. 6.5 Celladon
  26. 6.5.1 Celladon Company Information
  27. 6.5.2 Celladon Business Overview
  28. 6.5.3 Celladon Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Celladon Gene Therapy Medicine Product Portfolio
  30. 6.5.5 Celladon Recent Developments
  31. 6.6 Bluebird Bio
  32. 6.6.1 Bluebird Bio Company Information
  33. 6.6.2 Bluebird Bio Business Overview
  34. 6.6.3 Bluebird Bio Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Bluebird Bio Gene Therapy Medicine Product Portfolio
  36. 6.6.5 Bluebird Bio Recent Developments
  37. 6.7 Avalanche Bio
  38. 6.7.1 Avalanche Bio Company Information
  39. 6.7.2 Avalanche Bio Business Overview
  40. 6.7.3 Avalanche Bio Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Avalanche Bio Gene Therapy Medicine Product Portfolio
  42. 6.7.5 Avalanche Bio Recent Developments
  43. 6.8 Advantagene
  44. 6.8.1 Advantagene Company Information
  45. 6.8.2 Advantagene Business Overview
  46. 6.8.3 Advantagene Gene Therapy Medicine Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Advantagene Gene Therapy Medicine Product Portfolio
  48. 6.8.5 Advantagene Recent Developments
7 North America
  1. 7.1 North America Gene Therapy Medicine Market Size (2021-2032)
  2. 7.2 North America Gene Therapy Medicine Market Size by Type
  3. 7.2.1 North America Gene Therapy Medicine Market Size by Type (2021-2026)
  4. 7.2.2 North America Gene Therapy Medicine Market Size by Type (2027-2032)
  5. 7.2.3 North America Gene Therapy Medicine Market Share by Type (2021-2032)
  6. 7.3 North America Gene Therapy Medicine Market Size by Application
  7. 7.3.1 North America Gene Therapy Medicine Market Size by Application (2021-2026)
  8. 7.3.2 North America Gene Therapy Medicine Market Size by Application (2027-2032)
  9. 7.3.3 North America Gene Therapy Medicine Market Share by Application (2021-2032)
  10. 7.4 North America Gene Therapy Medicine Market Size by Country
  11. 7.4.1 North America Gene Therapy Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Gene Therapy Medicine Market Size by Country (2021-2026)
  13. 7.4.3 North America Gene Therapy Medicine Market Size by Country (2027-2032)
  14. 7.4.4 North America Gene Therapy Medicine Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Gene Therapy Medicine Market Size (2021-2032)
  2. 8.2 Europe Gene Therapy Medicine Market Size by Type
  3. 8.2.1 Europe Gene Therapy Medicine Market Size by Type (2021-2026)
  4. 8.2.2 Europe Gene Therapy Medicine Market Size by Type (2027-2032)
  5. 8.2.3 Europe Gene Therapy Medicine Market Share by Type (2021-2032)
  6. 8.3 Europe Gene Therapy Medicine Market Size by Application
  7. 8.3.1 Europe Gene Therapy Medicine Market Size by Application (2021-2026)
  8. 8.3.2 Europe Gene Therapy Medicine Market Size by Application (2027-2032)
  9. 8.3.3 Europe Gene Therapy Medicine Market Share by Application (2021-2032)
  10. 8.4 Europe Gene Therapy Medicine Market Size by Country
  11. 8.4.1 Europe Gene Therapy Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Gene Therapy Medicine Market Size by Country (2021-2026)
  13. 8.4.3 Europe Gene Therapy Medicine Market Size by Country (2027-2032)
  14. 8.4.4 Europe Gene Therapy Medicine Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Gene Therapy Medicine Market Size (2021-2032)
  2. 9.2 China Gene Therapy Medicine Market Size by Type
  3. 9.2.1 China Gene Therapy Medicine Market Size by Type (2021-2026)
  4. 9.2.2 China Gene Therapy Medicine Market Size by Type (2027-2032)
  5. 9.2.3 China Gene Therapy Medicine Market Share by Type (2021-2032)
  6. 9.3 China Gene Therapy Medicine Market Size by Application
  7. 9.3.1 China Gene Therapy Medicine Market Size by Application (2021-2026)
  8. 9.3.2 China Gene Therapy Medicine Market Size by Application (2027-2032)
  9. 9.3.3 China Gene Therapy Medicine Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Gene Therapy Medicine Market Size (2021-2032)
  2. 10.2 Asia Gene Therapy Medicine Market Size by Type
  3. 10.2.1 Asia Gene Therapy Medicine Market Size by Type (2021-2026)
  4. 10.2.2 Asia Gene Therapy Medicine Market Size by Type (2027-2032)
  5. 10.2.3 Asia Gene Therapy Medicine Market Share by Type (2021-2032)
  6. 10.3 Asia Gene Therapy Medicine Market Size by Application
  7. 10.3.1 Asia Gene Therapy Medicine Market Size by Application (2021-2026)
  8. 10.3.2 Asia Gene Therapy Medicine Market Size by Application (2027-2032)
  9. 10.3.3 Asia Gene Therapy Medicine Market Share by Application (2021-2032)
  10. 10.4 Asia Gene Therapy Medicine Market Size by Country
  11. 10.4.1 Asia Gene Therapy Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Gene Therapy Medicine Market Size by Country (2021-2026)
  13. 10.4.3 Asia Gene Therapy Medicine Market Size by Country (2027-2032)
  14. 10.4.4 Asia Gene Therapy Medicine Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Gene Therapy Medicine Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Gene Therapy Medicine Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Gene Therapy Medicine Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Gene Therapy Medicine Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Gene Therapy Medicine Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Gene Therapy Medicine Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Gene Therapy Medicine Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Gene Therapy Medicine Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Gene Therapy Medicine Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Gene Therapy Medicine Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Gene Therapy Medicine Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Gene Therapy Medicine Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Gene Therapy Medicine Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Gene Therapy Medicine Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst